FILIBREE Trademark

Trademark Overview


On Thursday, November 2, 2017, a trademark application was filed for FILIBREE with the United States Patent and Trademark Office. The USPTO has given the FILIBREE trademark a serial number of 87669506. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, August 12, 2019. This trademark is owned by Pfizer Inc.. The FILIBREE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
filibree

General Information


Serial Number87669506
Word MarkFILIBREE
Filing DateThursday, November 2, 2017
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, August 12, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, August 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, August 12, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, August 12, 2019ABANDONMENT - AFTER PUBLICATION
Friday, August 9, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Friday, August 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2019EXTENSION 2 GRANTED
Thursday, July 11, 2019EXTENSION 2 FILED
Thursday, July 11, 2019TEAS EXTENSION RECEIVED
Wednesday, November 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 26, 2018EXTENSION 1 GRANTED
Monday, November 26, 2018EXTENSION 1 FILED
Monday, November 26, 2018TEAS EXTENSION RECEIVED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 6, 2018ASSIGNED TO LIE
Monday, April 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 8, 2018NON-FINAL ACTION E-MAILED
Thursday, February 8, 2018NON-FINAL ACTION WRITTEN
Friday, February 2, 2018ASSIGNED TO EXAMINER
Monday, November 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 6, 2017NEW APPLICATION ENTERED IN TRAM